INNOVA CAPTAB
|
INNOVA CAPTAB Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 22.41 | 16.49 | 14.16 | 531.54 | 286.86 |
| CEPS(Rs) | 26.74 | 19.28 | 16.46 | 14.89 | 8.35 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 167.66 | 145.20 | 57.61 | 1,738.38 | 1,206.84 |
| Tax Rate(%) | 25.00 | 27.16 | 25.97 | 25.39 | 25.56 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 14.71 | 14.25 | 12.09 | 11.88 | 13.24 |
| EBIT Margin(%) | 13.70 | 13.93 | 11.89 | 11.31 | 12.21 |
| Pre Tax Margin(%) | 13.51 | 11.95 | 9.76 | 10.60 | 11.26 |
| PAT Margin (%) | 10.13 | 8.71 | 7.23 | 7.91 | 8.38 |
| Cash Profit Margin (%) | 12.09 | 10.18 | 8.41 | 8.84 | 9.74 |
| Performance Ratios | |||||
| ROA(%) | 8.78 | 9.08 | 9.99 | 12.58 | 10.48 |
| ROE(%) | 14.33 | 17.04 | 28.02 | 36.19 | 27.04 |
| ROCE(%) | 14.65 | 19.06 | 24.34 | 30.64 | 28.42 |
| Asset Turnover(x) | 0.87 | 1.04 | 1.38 | 1.59 | 1.25 |
| Sales/Fixed Asset(x) | 1.94 | 3.48 | 4.46 | 5.17 | 4.10 |
| Working Capital/Sales(x) | 3.69 | 3.45 | 5.70 | 9.56 | 7.44 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.52 | 0.29 | 0.22 | 0.19 | 0.24 |
| Receivable days | 89.43 | 93.25 | 92.78 | 79.30 | 99.91 |
| Inventory Days | 50.76 | 44.01 | 47.70 | 49.63 | 69.58 |
| Payable days | 108.88 | 106.52 | 100.16 | 88.60 | 122.96 |
| Valuation Parameters | |||||
| PER(x) | 39.15 | 27.18 | - | - | - |
| PCE(x) | 32.81 | 23.25 | - | - | - |
| Price/Book(x) | 5.23 | 3.09 | - | - | - |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 4.25 | 2.52 | 0.29 | 0.26 | 0.11 |
| EV/Core EBITDA(x) | 26.69 | 16.29 | 2.15 | 2.10 | 0.81 |
| EV/EBIT(x) | 30.50 | 18.01 | 2.36 | 2.27 | 0.90 |
| EV/CE(x) | 4.08 | 2.54 | 0.52 | 0.34 | 0.11 |
| M Cap / Sales | 4.04 | 2.37 | - | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 15.02 | 16.72 | 15.72 | 94.94 | 10.00 |
| Core EBITDA Growth(%) | 18.72 | 35.90 | 24.21 | 77.06 | 6.94 |
| EBIT Growth(%) | 14.86 | 35.09 | 22.28 | 81.81 | 19.25 |
| PAT Growth(%) | 35.95 | 38.84 | 6.26 | 85.37 | 23.72 |
| EPS Growth(%) | 35.95 | 16.46 | -97.34 | 85.30 | 23.53 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.35 | 0.29 | 0.85 | 0.95 | 0.31 |
| Current Ratio(x) | 1.91 | 2.07 | 1.59 | 1.27 | 1.26 |
| Quick Ratio(x) | 1.36 | 1.58 | 1.17 | 0.86 | 0.83 |
| Interest Cover(x) | 72.11 | 7.04 | 5.60 | 16.09 | 12.80 |
| Total Debt/Mcap(x) | 0.07 | 0.09 | - | - | - |
Compare Financial Ratios of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹3,949.4 Cr | -4.9% | -6.3% | -33.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,705.0 Cr | -0.7% | 2% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,091.0 Cr | -2.1% | -2.8% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,555.0 Cr | -0.9% | -0.6% | 12.2% | Stock Analytics | |
| CIPLA | ₹120,919.0 Cr | -1% | -1.2% | 3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,165.0 Cr | -0.1% | 2.3% | 2.6% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | -4.9% |
-6.3% |
-33.3% |
| SENSEX | 0.2% |
-0.5% |
4% |
You may also like the below Video Courses
